Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasim Mavaddat

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Journal of Chemical Information and Modeling|November 29, 2005
Reaction between ellagic acid and an ultimate carcinogenPhilippe Huetz, Nasim Mavaddat, Janez Mavri
BMJ (Clinical Research Ed.)|September 29, 2023
Religion and health: complexities and contradictionsNasim Mavaddat, Nahal Mavaddat, Peymané Adab, et al.
Molecular Oncology|June 15, 2010
Genetic susceptibility to breast cancerNasim Mavaddat, Antonis C Antoniou, Douglas F Easton, et al.
Lancet (London, England)|July 12, 2016
Post-sanctions era in Iran: opportunity for science and publicationPeymane Adab, Nasim Mavaddat, Christopher Lee, et al.
Breast Cancer Research : BCR|May 21, 2010
Incorporating tumour pathology information into breast cancer risk prediction algorithmsNasim Mavaddat, Timothy R Rebbeck, Sunil R Lakhani, et al.
European Journal of Immunology|October 15, 2005
Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligandAlexandra Rizzitelli, David Vremec, Jose A Villadangos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinaseDavid Pozo, Mar Valés-Gómez, Nasim Mavaddat, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 2009
Common genetic variation in candidate genes and susceptibility to subtypes of breast cancerNasim Mavaddat, Alison M Dunning, Bruce A J Ponder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2025
Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast DiseaseJasmine Timbres, Kelly Kohut, Nasim Mavaddat, et al.
Nature Structural Biology|September 6, 2003
The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4DChristopher A Love, Karl Harlos, Nasim Mavaddat, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Journal of Chemical Information and Modeling|November 29, 2005
Reaction between ellagic acid and an ultimate carcinogenPhilippe Huetz, Nasim Mavaddat, Janez Mavri
BMJ (Clinical Research Ed.)|September 29, 2023
Religion and health: complexities and contradictionsNasim Mavaddat, Nahal Mavaddat, Peymané Adab, et al.
Molecular Oncology|June 15, 2010
Genetic susceptibility to breast cancerNasim Mavaddat, Antonis C Antoniou, Douglas F Easton, et al.
Lancet (London, England)|July 12, 2016
Post-sanctions era in Iran: opportunity for science and publicationPeymane Adab, Nasim Mavaddat, Christopher Lee, et al.
Breast Cancer Research : BCR|May 21, 2010
Incorporating tumour pathology information into breast cancer risk prediction algorithmsNasim Mavaddat, Timothy R Rebbeck, Sunil R Lakhani, et al.
European Journal of Immunology|October 15, 2005
Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligandAlexandra Rizzitelli, David Vremec, Jose A Villadangos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinaseDavid Pozo, Mar Valés-Gómez, Nasim Mavaddat, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 2009
Common genetic variation in candidate genes and susceptibility to subtypes of breast cancerNasim Mavaddat, Alison M Dunning, Bruce A J Ponder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2025
Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast DiseaseJasmine Timbres, Kelly Kohut, Nasim Mavaddat, et al.
Nature Structural Biology|September 6, 2003
The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4DChristopher A Love, Karl Harlos, Nasim Mavaddat, et al.
Pageof 5